Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
cccc
/
C4 Therapeutics Inc
CCCC
Add to Watchlist
3.480
USD
-0.180
-4.92%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
3.660
USD
+3.660
After-hours 08/03, 20:00 (ET)
384.77M
Market Cap
Loss
P/E TTM
C4 Therapeutics Inc
3.480
-0.180
-4.92%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Point72 Asset Management, L.P.
8.54%
Morgan Stanley & Co. LLC
8.10%
RA Capital Management, LP
7.24%
Lynx1 Capital Advisors LLC
6.33%
Vanguard Capital Management, LLC
3.49%
Other
66.30%
Shareholders
Shareholders
Proportion
Point72 Asset Management, L.P.
8.54%
Morgan Stanley & Co. LLC
8.10%
RA Capital Management, LP
7.24%
Lynx1 Capital Advisors LLC
6.33%
Vanguard Capital Management, LLC
3.49%
Other
66.30%
Shareholder Types
Shareholders
Proportion
Investment Advisor
24.05%
Hedge Fund
20.77%
Research Firm
12.49%
Venture Capital
7.36%
Investment Advisor/Hedge Fund
6.20%
Individual Investor
1.88%
Private Equity
1.28%
Bank and Trust
0.59%
Pension Fund
0.21%
Other
25.17%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
296
76.03M
69.01%
-8.78M
2025Q4
294
70.34M
70.90%
+17.39M
2025Q3
308
52.96M
108.83%
-2.15M
2025Q2
306
55.08M
118.23%
-10.19M
2025Q1
320
64.50M
110.39%
-13.86M
2024Q4
320
64.84M
109.43%
+173.51K
2024Q3
315
64.67M
104.71%
+3.40M
2024Q2
309
61.26M
103.56%
+2.76M
2024Q1
313
58.50M
89.36%
-2.80M
2023Q4
309
47.27M
101.07%
+10.16M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Point72 Asset Management, L.P.
9.44M
9.67%
+961.68K
+11.34%
Dec 31, 2025
Morgan Stanley & Co. LLC
8.96M
9.18%
+4.09M
+84.18%
Dec 31, 2025
RA Capital Management, LP
8.00M
8.2%
--
--
Dec 31, 2025
Lynx1 Capital Advisors LLC
7.10M
7.27%
--
--
Dec 31, 2025
Soleus Capital Management, L.P.
3.80M
3.9%
-3.25M
-46.07%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
3.13M
3.21%
+1.11M
+55.05%
Dec 31, 2025
Wasatch Global Investors Inc
4.34M
4.45%
-507.82K
-10.46%
Dec 31, 2025
Two Sigma Investments, LP
2.58M
2.64%
+979.98K
+61.33%
Dec 31, 2025
BofA Global Research (US)
2.39M
2.45%
+334.42K
+16.29%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
View more
iShares Micro-Cap ETF
Proportion
0.03%
Fidelity Enhanced Small Cap ETF
Proportion
0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proportion
0.02%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.02%
Invesco Nasdaq Biotechnology ETF
Proportion
0.02%
iShares Biotechnology ETF
Proportion
0.01%
Avantis US Small Cap Equity ETF
Proportion
0.01%
ProShares Hedge Replication ETF
Proportion
0%
iShares Russell 2000 Value ETF
Proportion
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion
0%